Evidence map›Paper›PMID 31572358›Full record

ArticleFrontiers in immunology2019

Rochelle D Vergroesen, Linda M Slot, Barbera D C van Schaik, Marvyn T Koning, Theo Rispens, Antoine H C van Kampen, René E M Toes, Hans U Scherer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Glycobiology of rheumatic diseases.Nature reviews. Rheumatology · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. H and L Chain Affinity Maturation and/or FabJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rochelle D VergroesenDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Linda M SlotDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Barbera D C van SchaikBioinformatics Laboratory, Amsterdam Public Health Research Institute, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Marvyn T KoningDepartment of Hematology, Leiden University Medical Center, Leiden, Netherlands.
Theo RispensDepartment of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, Netherlands.
Antoine H C van KampenBioinformatics Laboratory, Amsterdam Public Health Research Institute, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
René E M ToesDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Hans U SchererDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Leiden University Medical Center · NLUniversity of Amsterdam · NLSanquin · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many autoimmune diseases are hallmarked by autoreactive B and plasma cell responses that are directly or indirectly involved in disease pathogenesis. These B-cell responses show large variability between diseases, both in terms of the secreted autoantibody repertoire and the dynamics and characteristics of the underlying B-cell responses. Hence, different mechanisms have been proposed to explain the emergence of autoreactive B cells in an otherwise self-tolerant immune system. Notably, most mechanistic insights have been obtained from murine studies using models harboring genetic modifications of B and T cells. Given recent technological advances that have rendered autoreactive human B cells accessible for analysis, we here discuss the phenomenon of extensive

Indexed as

GlycosylationAnti-Citrullinated Protein AntibodiesArthritis, RheumatoidB-LymphocytesCitrullinationCross ReactionsHumansImmunoglobulin GReceptors, Antigen, B-CellAnti-Citrullinated Protein AntibodiesImmunoglobulin GReceptors, Antigen, B-Cellanti-citrullinated protein antibodiesB cellsgerminal centerglycosylationrheumatoid arthritisvariable domain (Fab)

Identifiers

PMID31572358
PMCPMC6749139
OpenAlexW2969646352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.